Mechanisms of action of antiarrhythmic drugs.
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000503:physiopathology; D003864:Depression, Chemical; D004285:Dogs; D006321:Heart / Q000502:physiology; D006325:Heart Atria / Q000187:drug effects; D006327:Heart Block / Q000503:physiopathology; D006329:Heart Conduction System / Q000502:physiology / Q000503:physiopathology; D006801:Humans; D008012:Lidocaine / Q000494:pharmacology; D008564:Membrane Potentials / Q000187:drug effects; D010477:Perfusion; D010672:Phenytoin / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D011342:Procainamide / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology; D012032:Refractory Period, Electrophysiological / Q000187:drug effects
D000889:Anti-Arrhythmia Agents; D010672:Phenytoin; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide; D011188:Potassium